Pamela M. Quizon

548 total citations
18 papers, 405 citations indexed

About

Pamela M. Quizon is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Pamela M. Quizon has authored 18 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Virology and 8 papers in Infectious Diseases. Recurrent topics in Pamela M. Quizon's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (8 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Pamela M. Quizon is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (8 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Pamela M. Quizon collaborates with scholars based in United States, Belgium and Italy. Pamela M. Quizon's co-authors include Wei‐Lun Sun, Jun Zhu, Chang‐Guo Zhan, Yaxia Yuan, Brian J. Bennett, Narasimha M. Midde, Annalouise O’Connor, Xiaoqin Huang, Daniel Pomp and Daniel M. Gatti and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Pamela M. Quizon

17 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela M. Quizon United States 12 192 102 98 70 57 18 405
Alexia Harrist United States 9 227 1.2× 179 1.8× 36 0.4× 64 0.9× 30 0.5× 13 531
Julia A. Najera United States 11 169 0.9× 99 1.0× 95 1.0× 32 0.5× 18 0.3× 15 700
Xiuzhen Fan United States 12 180 0.9× 129 1.3× 49 0.5× 43 0.6× 16 0.3× 20 431
Tess M. Eidem United States 10 290 1.5× 110 1.1× 31 0.3× 59 0.8× 54 0.9× 13 763
Ana Borrajo Spain 13 213 1.1× 182 1.8× 124 1.3× 63 0.9× 38 0.7× 21 701
Kunlin Zhang China 11 176 0.9× 34 0.3× 57 0.6× 47 0.7× 54 0.9× 25 699
Ulla Hasselrot United States 10 214 1.1× 180 1.8× 227 2.3× 36 0.5× 20 0.4× 14 494
Rollie Reid United States 9 159 0.8× 98 1.0× 276 2.8× 45 0.6× 20 0.4× 9 532
Franck Mouthon France 17 337 1.8× 95 0.9× 30 0.3× 63 0.9× 16 0.3× 35 655

Countries citing papers authored by Pamela M. Quizon

Since Specialization
Citations

This map shows the geographic impact of Pamela M. Quizon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela M. Quizon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela M. Quizon more than expected).

Fields of papers citing papers by Pamela M. Quizon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela M. Quizon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela M. Quizon. The network helps show where Pamela M. Quizon may publish in the future.

Co-authorship network of co-authors of Pamela M. Quizon

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela M. Quizon. A scholar is included among the top collaborators of Pamela M. Quizon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela M. Quizon. Pamela M. Quizon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Quizon, Pamela M., Sarah E. Davis, Yaxia Yuan, et al.. (2022). Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function. PLoS ONE. 17(9). e0275182–e0275182. 5 indexed citations
2.
Quizon, Pamela M., Yaxia Yuan, Yi Zhou, et al.. (2021). Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat‐inhibited Dopamine Transport. Journal of Neuroimmune Pharmacology. 16(4). 854–869. 6 indexed citations
3.
Ogata, Yuko, Pamela M. Quizon, Nancy S. Nightlinger, et al.. (2021). Automated multi‐attribute method sample preparation using high‐throughput buffer exchange tips. Rapid Communications in Mass Spectrometry. 36(3). e9222–e9222. 14 indexed citations
4.
5.
6.
Sun, Wei‐Lun, Pamela M. Quizon, Yaxia Yuan, et al.. (2017). Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter. Scientific Reports. 7(1). 3694–3694. 11 indexed citations
7.
Yuan, Yaxia, et al.. (2016). Role of Histidine 547 of Human Dopamine Transporter in Molecular Interaction with HIV-1 Tat and Dopamine Uptake. Scientific Reports. 6(1). 27314–27314. 13 indexed citations
8.
Quizon, Pamela M., Wei‐Lun Sun, Yaxia Yuan, et al.. (2016). Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport. Scientific Reports. 6(1). 39048–39048. 18 indexed citations
9.
Zhu, Jun, Yaxia Yuan, Narasimha M. Midde, et al.. (2015). HIV-1 transgenic rats display an increase in [3H]dopamine uptake in the prefrontal cortex and striatum. Journal of NeuroVirology. 22(3). 282–292. 16 indexed citations
10.
Midde, Narasimha M., Yaxia Yuan, Pamela M. Quizon, et al.. (2015). Mutations at Tyrosine 88, Lysine 92 and Tyrosine 470 of Human Dopamine Transporter Result in an Attenuation of HIV-1 Tat-Induced Inhibition of Dopamine Transport. Journal of Neuroimmune Pharmacology. 10(1). 122–135. 24 indexed citations
11.
Sun, Wei‐Lun, Pamela M. Quizon, & Jun Zhu. (2015). Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects. Progress in molecular biology and translational science. 137. 1–40. 55 indexed citations
12.
Yuan, Yaxia, Xiaoqin Huang, Narasimha M. Midde, et al.. (2015). Molecular Mechanism of HIV-1 Tat Interacting with Human Dopamine Transporter. ACS Chemical Neuroscience. 6(4). 658–665. 38 indexed citations
13.
Quizon, Pamela M., et al.. (2014). Genetic network identifies novel pathways contributing to atherosclerosis susceptibility in the innominate artery. BMC Medical Genomics. 7(1). 51–51. 7 indexed citations
14.
O’Connor, Annalouise, et al.. (2014). Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics. Mammalian Genome. 25(11-12). 583–599. 53 indexed citations
15.
Bennett, Brian J., et al.. (2014). Mapping metabolic traits in the diversity outbred mouse population (818.12). The FASEB Journal. 28(S1). 1 indexed citations
16.
Gatti, Daniel M., Pamela M. Quizon, George M. Weinstock, et al.. (2014). High-Resolution Genetic Mapping in the Diversity Outbred Mouse Population Identifies Apobec1 as a Candidate Gene for Atherosclerosis. G3 Genes Genomes Genetics. 4(12). 2353–2363. 39 indexed citations
17.
O’Connor, Annalouise, et al.. (2014). Diet and genetic‐induced differences in the intestinal microbiome relate to cardiometabolic phenotype (637.13). The FASEB Journal. 28(S1). 1 indexed citations
18.
Naidoo, Vinogran, David A. Karanian, Subramanian K. Vadivel, et al.. (2012). Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology. Neurotherapeutics. 9(4). 801–813. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026